Paronychia in Association with Indinavir Treatment
Open Access
- 1 January 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (1) , 140-143
- https://doi.org/10.1086/317546
Abstract
To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment—adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures—was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6–13.9).Keywords
This publication has 7 references indexed in Scilit:
- Paronychia and Pyogenic Granuloma of the Great Toes in Patients Treated with IndinavirNew England Journal of Medicine, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Lamivudine-induced paronychiaThe Lancet, 1998
- Nail changes secondary to systemic drugs or ingestantsJournal of the American Academy of Dermatology, 1984
- Etretinate therapy for psoriasis: Clinical responses, remission times, epidermal DNA and polyamine responsesJournal of the American Academy of Dermatology, 1983
- COSTAR—A computer-based medical information system for ambulatory careProceedings of the IEEE, 1979
- Covariance Analysis of Heart Transplant Survival DataJournal of the American Statistical Association, 1977